FindTrial
Sign In

Effect of anesthetic exposure times on propofol dosage requirement in patients treated with painless bronchoscopy

Effect of anesthetic exposure times on propofol dosage requirement in patients treated with painless bronchoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098647
Enrollment
Unknown
Registered
2025-03-12
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Number of anesthesia exposures

Interventions

Observations group:None

Sponsors

Anesthesiology Department, The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years; 2. general anesthesia; 3. bronchoscopy

Exclusion criteria

Exclusion criteria: 1. ASA grade > IV; 2. Severe liver dysfunction (Child-Pugh grade C); 3. Severe renal dysfunction (requiring kidney replacement therapy); 4. Combined with cognitive dysfunction; 5. Lack of information; 6. Allergic to known narcotic drugs.

Design outcomes

Primary

MeasureTime frame
The amount of propofol required to achieve an adequate depth of anesthetic sedation;—

Secondary

MeasureTime frame
Remifentanil dosage;Duration of anesthetic maintenance;Recovery time;recovery time of spontaneous breathing;removal time of laryngeal mask;—

Countries

China

Contacts

Public ContactCheng Bo

The First Affiliated Hospital of Chongqing Medical University

1031493720@qq.com+86 139 8376 0123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026